Old Web
English
Sign In
Acemap
>
Paper
>
Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High-Risk Patients with COVID-19
Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High-Risk Patients with COVID-19
2021
Spyridoula Vasileiou
Manik Kuvalekar
Aster Workineh
Ayumi Watanabe
Yovana Velazquez
Suhasini Lulla
Helen E. Heslop
Kimberly Mooney
Kevin Grimes
George Carrum
LaQuisa Hill
Premal Lulla
Ann M. Leen
Keywords:
Medicine
off the shelf
severe acute respiratory syndrome coronavirus 2
Coronavirus disease 2019
high risk patients
Virology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]